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Adult wound healing is characterized by an exuberant inflammatory response and scar formation. In contrast,
scarless fetal wound healing has diminished inflammation, a lack of fibroplasia, and restoration of normal
architecture. We have previously shown that fetal wounds produce less inflammatory cytokines, and the
absence of IL-10, an anti-inflammatory cytokine, results in fetal scar formation. We hypothesized that increased
IL-10 would decrease inflammation and create an environment conducive for regenerative healing in the adult.
To test this hypothesis, a lentiviral vector expressing IL-10 and green fluorescent protein (GFP) (Lenti-IL-10) or
GFP alone (Lenti-GFP) was injected at the wound site 48 hours before wounding. We found that both Lenti-IL-10
and Lenti-GFP were expressed in the wounds at 1 and 3 days post wounding. At 3 days, Lenti-IL-10-treated
wounds demonstrated decreased inflammation and decreased quantities of all proinflammatory mediators
analyzed with statistically different levels of IL-6, monocyte chemoattractant protein-1, and heat-shock protein
47. At 3 weeks, Lenti-GFP wounds demonstrated scar formation. In contrast, wounds injected with Lenti-IL-10
demonstrated decreased inflammation, a lack of abnormal collagen deposition, and restoration of normal
dermal architecture. We conclude that lentivirus-mediated overexpression of IL-10 decreases the inflammatory
response to injury, creating an environment conducive for regenerative adult wound healing.
Journal of Investigative Dermatology (2008) 128, 1852–1860; doi:10.1038/sj.jid.5701232; published online 17 January 2008
INTRODUCTION
Normal wound healing follows an orderly sequence of events
beginning with inflammation, followed by cellular prolifera-
tion and formation of new tissue, and finally by tissue
remodeling. The initial inflammatory stage is characterized
by local activation of the innate immune system, with the
subsequent influx of neutrophilic granulocytes and macro-
phages (Martin, 1997). These infiltrating cells then produce a
number of different inflammatory mediators, the balance of
which is partially responsible for modulating the repair
process (Martin, 1997). Although physiological, the brisk
inflammatory response, cellular proliferation, and extra-
cellular matrix (ECM) deposition associated with wounding
result in rapid repair, but are also associated with scar
formation. Fibroplasia or scar formation is a complication of
many disease processes as well as their therapies, such as
adhesions following bowel surgery, joint contractures after
orthopedic procedures, or keloid formation after any dermal
injury (Tredget et al., 1997; Ellis et al., 1999; Manske, 2005).
In contrast to fibroplasia and scar formation seen in adult
wound healing, fetal dermal wound healing is characterized
by a markedly diminished inflammatory response, a lack of
abnormal ECM deposition, and restoration of normal dermal
architecture (Adzick et al., 1985; Krummel et al., 1987;
Longaker et al., 1990). This regenerative process has been
shown to be associated with scarless healing (Burrington,
1971).
Although the definitive mechanism of scarless fetal wound
healing remains to be elucidated, diminished inflammation in
fetal wounds is well recognized. Studies suggest that the lack
of inflammation associated with scarless fetal wound healing
is related to the balance of pro- and anti-inflammatory
cytokines present in the fetal environment. Specifically, the
production of the proinflammatory cytokines IL-6 and IL-8 is
decreased during scarless fetal wound repair, and fetal
fibroblasts produce significantly less IL-6 and IL-8 when
stimulated with platelet-derived growth factor (Liechty et al.,
1998, 2000a). IL-10 has also been suggested to play an
important role in scarless fetal wound healing. IL-10 is known
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to be a major regulator in suppressing the inflammatory
response (Moore et al., 1993). In addition to inhibiting the
expression of proinflammatory cytokines, including IL-6 and
IL-8, IL-10 has also been shown to inhibit the migration of
inflammatory cells, including monocytes, neutrophils, and
macrophages, to sites of injury, by inhibiting the expression
of specific chemokines, including macrophage inflammatory
protein-1a (MIP-1a) and monocyte chemoattractant protein-1
(MCP-1) (de Waal Malefyt et al., 1991; Fiorentino et al.,
1991; Alam et al., 1994; DiPietro et al., 1995, 1998;
Fortunato et al., 1996, 1998; Elgert et al., 1998; Engelhardt
et al., 1998). Evidence also suggests that IL-10 may play a
specific anti-inflammatory role during pregnancy, highlight-
ing its presence and potential activity in the fetus. It is known
to be present in amniotic fluid and its anti-inflammatory
function is postulated to play an important role in the
prevention of an inflammatory response to the fetus and fetal
‘‘foreign’’ antigens (Heyborne et al., 1994; Cadet et al.,
1995). Finally, with respect to scar formation and fibrosis
following wounding, the absence of IL-10 in IL-10 knockout
mice results in scar formation in fetal wounds that would
otherwise heal with a scarless phenotype (Liechty et al.,
2000b).
Based on the known anti-inflammatory properties of IL-10
and previous studies suggesting the importance of the lack of
inflammation and inflammatory mediators in scarless wound
repair, we hypothesized that the overexpression of IL-10 in an
adult murine model of dermal wound healing would create
an environment conducive to scarless wound healing. To test
this hypothesis, the elements of scar formation following
lentivirus-mediated IL-10 overexpression were evaluated in a
consistent and severe model of adult dermal scar formation.
Additionally, we evaluated the effect of IL-10 overexpression
on the production of proinflammatory/profibrotic mediators
and the presence of an inflammatory response in this model,
in an attempt to further clarify, mechanistically, the role of
IL-10 in regenerative wound healing.
RESULTS
Scar formation in an adult model of dermal wound healing
Scar formation was consistently and reproducibly produced
in our excisional adult murine model of dermal wound
healing following a 4-mm punch biopsy wound. Histologic
analysis of these wounds 3 weeks after injury repeatedly
demonstrated the elements of fibrosis and scar formation,
including a prominent cellular infiltrate, a lack of normal
dermal architecture such as hair follicles, and abnormal
collagen deposition (n¼ 4) (Figure 1). Similar results were
also seen when the wounds were harvested 2 weeks after
wounding (data not shown). An incisional wound-healing
model consisting of a 5-mm linear wound through the
epidermis and dermis was also evaluated. These wounds are
known to heal with less circumferential contraction and
granulation tissue than the normal excisional wounds
described above. In this less severe model, distinct elements
of scar formation, although present in some wounds, were
not consistently seen, highlighting the severity of scar
formation in the excisional wound model.
Lentiviral vector expression in vitro and in vivo
Stromal progenitor cells transduced in vitro with either
lentiviral vector expressing green fluorescent protein (GFP)
alone (Lenti-GFP) or lentiviral vector expressing IL-10 and
GFP (Lenti-IL-10) demonstrated GFP expression by 72 hours
post transduction (Figure S1a–d). To confirm that the GFP
expression seen following Lenti-IL-10 transduction was
associated with IL-10 protein production, supernatant from
transduced cells was evaluated by a murine IL-10-specific
ELISA. Increasing multiplicities of infection of Lenti-IL-10
transduction were associated with increasing concentrations
of IL-10 protein production, with the level of IL-10 produc-
tion exceeding the sensitivity of the test at multiplicities of
infection of 200, 400, and 800 (Figure S1e). In contrast,
transduction of stromal progenitor cells with Lenti-GFP did
not result in the production of IL-10 protein. To confirm that
the ability to transduce cells in vitro could be translated to
in vivo experiments, the wound bed from wounds injected
with both Lenti-GFP and Lenti-IL-10 was assessed at 1 (n¼ 5
per group) and 3 (n¼4 per group) days post wounding for
GFP expression, using fluorescent stereomicroscope. Both
Lenti-GFP- and Lenti-IL-10-injected wounds demonstrated
lentiviral transgene expression at the wound base, as
indicated by the expression of GFP (Figure 2).
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Figure 1. Model of scar formation following dermal wounding in adult mice.
Dermal wounding in 12- to 16-week-old C57BL/6 mice was performed with a
4-mm punch biopsy. Wounds were harvested 3 weeks post wounding and
analyzed by histology (n¼ 4). A representative wound after hematoxylin and
eosin (left column) and trichrome (right column) staining is depicted above at
original magnifications of 5 (a, b),  10 (c, d), and  20 (e, f), highlighting
the abnormal collagen deposition, cellular infiltrate, and lack of normal
dermal architecture. The wound edge is indicated by arrowheads (.) in
(a) and (b). Bar¼ 200, 100, and 50mm in (a), (c), and (e), respectively.
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Effect of IL-10 overexpression on wound phenotype
Having confirmed that the excisional model of adult dermal
wound healing resulted in consistent production of elements
of fibrosis and scar formation, as well as the ability to detect
lentivirus-mediated gene expression in this system, we next
assessed the effect of overexpression of IL-10 in this model.
The anticipated site of wounding was injected with either
Lenti-GFP (n¼5) or Lenti-IL-10 (n¼ 5) 48 hours before
wounding. Three weeks after wounding, the wounds were
harvested for assessment of fibrosis or scar formation.
Wounds injected with Lenti-GFP consistently displayed
abnormal collagen deposition, a significant cellular infiltrate,
and a lack of normal dermal architecture. Their histologic
appearance was similar to control wounds that had not been
injected with any viral vector, as depicted in Figure 1. In
contrast, wounds injected with Lenti-IL-10 failed to display
histologic elements of scar formation. These wounds had a
lack of abnormal collagen deposition, demonstrated restora-
tion of normal dermal architecture, including presence of hair
follicles, and appeared to have a decreased inflammatory cell
infiltrate compared with control wounds (Figure 3). To better
quantify the inflammatory cell infiltrate, the number of
CD45þ cells infiltrating the wound 3 days post wounding
in Lenti-GFP- (n¼ 4, 12 high-power fields) and Lenti-IL-10
(n¼4, 12 high-power fields)-injected mice was assessed by
immunohistochemistry for CD45. As shown in Figure 4,
wounds injected with Lenti-IL-10 had significantly fewer
inflammatory cells compared with wounds injected with
Lenti-GFP.
Comparison of the expression of proinflammatory and
profibrotic mediators in Lenti-IL-10- and Lenti-GFP-injected
wounds
IL-10 is an established anti-inflammatory cytokine and
scarless fetal wound healing has been associated with a
decrease in proinflammatory cytokines. We next assessed the
effect of IL-10 overexpression on the production of pro-
inflammatory and profibrotic cytokines/chemokines, 3 days
post wounding. Wounds were assessed for the expression of
the proinflammatory cytokines IL-6 and MIP-2; expression of
the chemokines MIP-1a and MCP-1, which have been
demonstrated to have chemoattractant activity for inflam-
matory cells, including monocytes, macrophages, T cells,
mast cells, and basophils; and for the expression of heat-
shock protein 47 (HSP47) which, along with MCP-1, has
been implicated in the development of fibrotic conditions
(Masuda et al., 1994; DiPietro et al., 1998; Ajuebor et al.,
1999; Dafforn et al., 2001; Ferreira et al., 2006). Expression
of all proinflammatory/profibrotic mediators as assessed by
reverse transcriptase-PCR and densitometry was less in Lenti-
IL-10-injected wounds compared with Lenti-GFP-injected
a b
c d
Figure 2. Lentiviral vector expression at the wound base. The anticipated
site of wounding was injected with Lenti-GFP (a, c) or Lenti-IL-10 (b, d)
48 hours before wounding. Wounds were harvested 1 (a, b) (n¼ 5) and 3
(c, d) (n¼4) days post wounding. The wound bed on the flank of the mouse
that remained after excision of the wound was assessed by fluorescence
stereomicroscopy for GFP expression. Exposure time¼2 seconds.
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Figure 3. IL-10 overexpression in dermal wounds decreases the elements of
scar formation. Wounds were injected with either Lenti-GFP (a–d) (n¼5) or
Lenti-IL-10 (e–h) (n¼5) 48 hours before wounding, harvested 3 weeks post
wounding, and analyzed by either hematoxylin and eosin (left column) or
trichrome staining (right panel) to highlight collagen deposition and
organization. Wounds are marked in India ink and the wound margins
indicated by arrowheads (.) in the  5 images. A hair follicle indicating the
elements of normal dermal architecture in the Lenti-IL-10-injected wound is
indicated by arrow. Original magnification:  5 (a, b, e, f);  10 (c, d, g, h).
Bar¼200 mm (a, e); 100mm (c, g).
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wounds, with the difference in the expression of IL-6, MCP-1,
and HSP47 reaching statistical significance (Figure 5).
DISCUSSION
Scar formation or fibroplasia is a common component of
adult wound healing. In contrast, fetal dermal wound healing
is a regenerative process characterized by a scarless
phenotype. The lack of inflammation in scarless fetal wound
healing is well established, and many studies attribute a fetal
environment supportive of scarless healing to a decreased
ability to produce proinflammatory cytokines or a shift in
balance from proinflammatory to anti-inflammatory cyto-
kines (Adzick et al., 1985; Krummel et al., 1987; Longaker
et al., 1990; Liechty et al., 1998, 2000a). In the current study,
we evaluate a consistent model of scar formation following
adult dermal wounding, and then manipulate this model by
overexpression of the anti-inflammatory cytokine IL-10 to
produce an environment conducive to regenerative healing.
Elements of a scarless phenotype following IL-10 over-
expression in this model included restoration of normal
dermal architecture, lack of abnormal collagen deposition,
and a decrease in inflammatory cell infiltrate. Mechanisti-
cally, the overexpression of IL-10 appears to influence the
wound-healing environment by decreasing the expression of
proinflammatory/profibrotic mediators, resulting in decreased
recruitment of inflammatory cells to the wound. In the current
study, this decreased inflammation was shown to occur at
3 days post wounding, and is believed to have a direct
relationship to the improved dermal wound architecture seen
at 3 weeks. The relationship between these events is based on
the known physiology of wound healing. In adult wound
healing, inflammatory cells recruited to the wound become
activated and produce more proinflammatory cytokines,
causing additional inflammation and cytokine production,
which stimulates keratinocyte migration/proliferation and
angiogenesis (Liechty et al., 2000a). These inflammatory
cells also produce growth factors that stimulate both
fibroblast proliferation and modification of the ECM, leading
to scar formation (Nanney et al., 1995; Roth et al., 1995).
Additionally, the previous finding that administration of
exogenous IL-6 to wounds that were expected to heal without
scar resulted in scar formation at 1 week post wounding,
further supports the relationship between decreased proin-
flammatory mediators at 3 days post wounding and a
regenerative wound healing phenotype at later time points
as suggested in the current study (Liechty et al., 2000a).
Although there was no significant difference in the
histologic analysis of Lenti-GFP-injected control wounds
and non-injected control wounds, the effect of Lenti-GFP
injection on cytokine production and inflammatory cell
infiltrate compared with non-injected control wounds was
not evaluated. Thus, the decrease in these elements following
Lenti-IL-10 injection when compared with Lenti-GFP injec-
tion may represent a decrease from elevated levels caused by
viral vector injection unrelated to wounding. However, the
observation that the Lenti-GFP-injected wounds were histo-
logically similar to non-injected control wounds led us to
believe that any increase in inflammatory factors caused by
lentiviral injection did not occur to the degree to significantly
affect the phenotype of the wound. The current study benefits
from the semi-quantitative objective analysis of the degree of
inflammatory cell infiltrate and gene expression. Although
the histologic evaluation of wound phenotype is descriptive
and somewhat subjective by nature, the phenotypic differ-
ences in Lenti-GFP- versus Lenti-IL10-treated wounds in the
current study are striking, with regards to more objective
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Figure 4. A decreased inflammatory cell infiltrate in Lenti-IL-10-injected
wounds. Immunofluorescent staining for CD45 demonstrates an increased
number of CD45þ cells in Lenti-GFP- (a) compared with Lenti-IL-10
(b)-injected wounds 3 days post wounding (blue, nucleus staining; green,
CD45 staining). When the number of CD45þ cells per high-power field (hpf)
is counted, the decrease in the number of cells in the Lenti-IL-10-injected
wounds reaches statistical significance, with P¼ 0.00014 (c). Bar¼ 25mm.
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Figure 5. Proinflammatory/profibrotic mediator expression in Lenti-GFP-
and Lenti-IL-10-treated wounds. Wounds from mice injected with either
Lenti-GFP or Lenti-IL-10 were harvested 3 days after wounding and assessed
by reverse transcriptase-PCR for the expression of proinflammatory/profibrotic
mediators (a). Expression of proinflammatory/profibrotic mediators was
quantified by densitometric analysis of gels, and standardized to
glyceraldehyde-3-phosphate dehydrogenase expression (b). *Po0.05;
#Po0.01
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histologic measures, specifically, cellular infiltrate; dermal
architecture, including the presence or absence of hair
follicles; and ECM composition. Finally, this study confirms
the ability to transduce both stromal progenitor cells (SPC)
in vitro and cells at the wound base in vivo, with lentiviral
vectors expressing IL-10, although the specific cell popula-
tion transduced in vivo was not identified and is not believed
to be an SPC, but is the subject of future studies.
An alternative approach to deliver IL-10 would involve
direct administration of the protein to the wound. Although
possible and warranting further study, we chose to evaluate a
gene therapy delivery method based on previous studies with
wound healing and platelet-derived growth factor in animals
and humans that have demonstrated the requirement of large
repeated doses of protein for a modest clinical response and,
in fact, a better response when a gene therapy based delivery
method was used (Liechty et al., 1999). We believe that a
lentiviral gene therapy delivery method would be more
advantageous than direct protein administration and still
remain safe. Its safety is suggested in the current study by the
inability to detect transduced cells by 3 weeks post
wounding, suggesting either clearance of the cells by the
immune system or silencing of the gene product. Future
studies are currently underway to determine the phenotype of
the transduced cells and their fates.
Although inflammation, scar formation, and fibroplasia are
important physiologic components of adult dermal wound
healing, they are also present in a large number of different
diseases. Thus, the application of the findings of the current
study to other disease models is exciting and invites further
investigation. The potential relationship between the results
of the current study and the ability of IL-10 overexpression to
influence other disease models becomes stronger upon
examination of the mechanistic control of inflammation in
these disease models. MCP-1 is a multifunctional inflam-
matory chemokine that is upregulated in a number of fibrotic
and inflammatory conditions, including idiopathic pulmon-
ary fibrosis, systemic sclerosis, and bleomycin-induced
scleroderma, in a mouse model. Its role in these diseases is
attributed both to its proinflammatory property as well as a
more direct effect on collagen deposition and fibrosis
(Rollins, 1996; Lloyd et al., 1997; Hasegawa et al., 1999;
Distler et al., 2001; Yamamoto and Nishioka, 2003; Ferreira
et al., 2006). HSPs are a group of proteins that are induced
when cells are exposed to stresses including infection,
ischemia, and tissue trauma. HSP47 is elevated in carbon
tetrachloride-induced rat liver fibrosis and bleomycine-
induced pulmonary fibrosis in the mouse and rat models
(Masuda et al., 1994; Razzaque et al., 1998; Ishii et al.,
2003). Additionally, elevated levels of HSP47 have been
implicated in the increased collagen deposition in renal
allograft tissue, arteriosclerosis, myocardial infarctions, renal
fibrosis, and pulmonary fibrosis, as well as in the peritoneum
of patients on continuous peritoneal dialysis (Sunamoto et al.,
1998a; Abe et al., 2000; Rocnik et al., 2000; Shioshita
et al., 2000; Takeda et al., 2000; Williams, 2000; Dafforn
et al., 2001). Finally, the reduction of HSP47 expression
was able to impede the disease process in a rat model of
glomerulonephritis (Sunamoto et al., 1998b). The multiple
episodes of elevated HSP47 and MCP-1 levels in these
diseases or disease models, as well as the ability to alter
disease progression by decreasing their expression, support a
role for HSP47 and MCP-1 in fibrotic processes. In the current
study, decreased inflammation and scar formation in a
dermal wound-healing model following IL-10 overexpression
was associated with statistically significant decreases in the
levels of both HSP47 and MCP-1 expression.
Finally, the potential to affect the pathologic outcome of
many diseases by increased expression of IL-10 is supported
by the finding of altered levels of IL-10 or its manipulation in
a number of the diseases. Serum levels of IL-10 have been
shown to be inversely related to the risk of coronary events in
patients with unstable angina or a previous myocardial
infarction (Smith et al., 2001; Anguera et al., 2002; Seljeflot
et al., 2004; Kilic et al., 2006). IL-10-deficient mice are more
susceptible to atherosclerosis and systemic delivery of IL-10
via plasmid DNA results in a 60% reduction in athero-
sclerotic plaque development in these mice (Mallat et al.,
1999). Similarly transplantation of bone marrow from IL-10
transgenic mice inhibits advanced atherosclerotic plaque
development in low-density lipoprotein receptor-null mice
(Pinderski et al., 2002). In pulmonary fibrosis, the role of
IL-10 and inflammation in the fibrotic process is uncertain
(Barbarin et al., 2005; Nakagome et al., 2006). However, at
least one study has demonstrated a reduction in fibrosis
following intravenous injection of IL-10 DNA in a murine
bleomycin-induced pulmonary fibrosis model (Nakagome
et al., 2006). In a rat model of chronic renal disease,
administration of IL-10 in a recombinant adeno-associated
virus vector resulted in decreased glomerulosclerosis and
interstitial fibrosis (Mu et al., 2005). The results of these
studies combined with the current study documenting a
decrease in inflammation and decreased expression of
proinflammatory/profibrotic cytokines following lentivirus-
mediated IL-10 expression, highlight the possibility of IL-10
overexpression to decrease fibrosis and inflammation in these
diseases or disease models, and potentially affect the
outcome of the disease.
The ability of IL-10 overexpression to decrease inflam-
mation and provide an environment supportive of scarless
wound healing is encouraging but must be approached with
caution. The wound-healing process is a series of tightly
regulated events, the manipulation of which may result in
unintended consequences. In normal adult dermal wound
healing, endogenous IL-10 is expressed with peak levels
occurring at 3 and 72 hours post wounding (Sato et al., 1999).
It is released both from resident skin cells and infiltrating
inflammatory cells (Moore et al., 1993). It is a major regulator
of inflammation and IL-10-deficient mice demonstrate an
increased number of inflammatory cells, including macro-
phages, at the wound sites. Evidence suggests that the lack of
IL-10 and increased infiltration of macrophages in these mice
is associated with accelerated wound closure via more rapid
epithelialization and enhanced wound contraction (Eming
et al., 2007). The addition of macrophages or macrophage-
activating substances to wounds has also been shown to
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increase the rate of wound closure (Leibovich and Danon,
1980; Mustoe et al., 1987; Danon et al., 1989). Additionally,
macrophages in wounds are documented to provide a
number of important functions, including production of
ECM molecules, proteases and protease inhibitors, and
production of growth factors (DiPietro et al., 1998). However,
despite the accelerated wound closure, the mechanical
strength of wounds in IL-10-deficient mice is reduced,
indicating that IL-10 affects the quality of the repaired tissue.
In our study, overexpression of IL-10 resulted in a decreased
inflammatory infiltrate, and preliminary results suggest that
macrophages are one of the cell populations affected. The
rate and strength of wound healing must be evaluated in our
model. These wounds heal with a decreased inflammatory
infiltrate and a more organized collagen deposition as a result
of IL-10 overexpression. We would expect that due to the
organized collagen deposition, these wounds would heal
with equal or better mechanical strength than control
wounds. However, the speed of wound closure may be
reduced.
The results presented here support the ability to provide an
environment supportive of a regenerative healing process that
is characteristic of scarless wound healing via IL-10 over-
expression. Mechanistically, this results from a shift to an
anti-inflammatory process characterized by decreased levels
of proinflammatory/profibrotic cytokines/chemokines. In the
current study, this shift was initiated by the injection of IL-10
before wounding. Future potential clinical applications may
require the application of IL-10 after the disease process has
already begun. Although these potential clinical applications
remain to be defined, this study serves as proof in principle
that the inflammatory response to injury can be manipulated
via lentiviral vector expression of IL-10, and that this
manipulation can alter the formation of scar and the
pathologic process.
MATERIALS AND METHODS
Animal model
All experimental protocols were approved by the Institutional
Animal Care and Use Committee at The Children’s Hospital of
Philadelphia, and followed guidelines set forth in the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals. To test our hypothesis, a reliable and reproducible model
of scar formation following dermal wounding in an adult murine
system was evaluated using 12- to 16-week-old C57BL/6 mice
(Jackson Laboratories, Bar Harbor, ME). Animals were housed in the
Laboratory Animal Facility of the Abramson Research Center at The
Children’s Hospital of Philadelphia. Under isoflurane anesthesia, the
hair on the flank of the mice was shaved and removed with Nair
(Church and Dwight Co., Princeton, NJ). A 4-mm dermal punch
biopsy was performed within the shaved area to outline a
standardized wound size, and the epidermis and dermis were
carefully dissected away. The wounds were marked with India ink,
covered with tegaderm (3M; Health Care, St Paul, MN), and
harvested at 3 weeks post wounding, at which time they were fixed
in 10% formaldehyde for subsequent histologic analysis. Wounds
were assessed microscopically for wound healing phenotype and
characteristics of scar formation, including presence of a cellular
infiltrate, loss of dermal appendages, and organization of collagen
deposition (n¼ 4).
To assess the effect of IL-10 overexpression in this wound-healing
model, 1 109 particle-forming units of a lentiviral vector expressing
either Lenti-IL-10 (n¼ 5) or Lenti-GFP (n¼ 5) were administered
intradermally, circumferentially around the anticipated site of
wounding, 48 hours before wounding. Similar to the wound-healing
model described above, wounds injected with a lentiviral vector
were harvested at 3 weeks post wounding and fixed in 10%
formaldehyde for histologic analysis of wound healing phenotype
and scar formation. In another study group, wounds from Lenti-
IL-10- (n¼ 4) and Lenti-GFP (n¼ 4)-injected animals were harvested
at 3 days post wounding and fixed in 10% formaldehyde for
immunofluorescent analysis of inflammatory cell infiltrate. In a final
study group, wounds injected with either Lenti-IL-10 or Lenti-GFP
were harvested at 1 (n¼ 5 per group) and 3 (n¼ 4 per group) days
post wounding, and the wound bed assessed with fluorescent
stereomicroscope for GFP expression. RNA was also isolated from
these wounds 3 days post wounding at the peak of the inflammatory
response, to assess for the expression of proinflammatory and
profibrotic cytokines/chemokines.
Lentiviral vector construct
A cDNA library was prepared from C57BL/6 bone marrow-derived
dendritic cells cultured in the presence of lipopolysaccharide
(1mgml1), using TRIzol reagent and Superscript (Invitrogen,
Carlsbad, CA), as per manufacturers’ recommendations. The mouse
IL-10-coding domain was amplified with the forward primer
50-GCGGCCGCGGTACCATGCCTGGCTCAGCACTG-30 and the
reverse primer 50-GCTAGCTTAGCTTTTCATTTTGATCATCATG-30,
using standard methods and confirmed by sequence analysis
(GenBank sequence accession number NM 010548). The flanking
NotI and NheI sites were inserted to simplify cloning into the HIV-1-
based transfer plasmid. The CS-CG HIV-1 transfer plasmid, modified
as previously described, was used to generate a self-inactivating
lentiviral vector (Naldini et al., 1996; Donello et al., 1998; Miyoshi
et al., 1998; Zennou et al., 2001). This lentiviral vector allows the
expression of the enhanced green fluorescent protein reporter gene
(Clontech Laboratories, Mountain View, CA) or IL-10 and enhanced
green fluorescent protein genes as a single transcript under the
control of the human cytomegalovirus promoter. For bicistronic gene
expression, the internal ribosome entry site, identical to that of the
encephalomyocarditis virus, was inserted between the IL-10 gene
and the enhanced green fluorescent protein reporter. Vesicular
stomatitis virus-G protein-pseudotyped viral particles were gener-
ated by transfection into a 293T cell line, and titered as previously
described (Sena-Esteves et al., 2004).
Histology
Formalin-fixed wounds were bisected and paraffin embedded as
previously described (Culling, 1974). Serial 5-mm sections of the
paraffin-embedded wounds were made using a 30/50 microtome
(Leica, Heerburgg, Switzerland) and collected on Superfrost Plus
slides (Fischer Scientific, Pittsburg, PA). Sections were subsequently
stained with either hematoxylin and eosin, or Masson’s trichrome, to
assess collagen production and distribution (Masson, 1929), or
processed for immunofluorescent staining for inflammatory cell
infiltrates as described below.
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Immunofluorescent staining
Wounds that had been injected with Lenti-IL-10 (n¼ 4) or Lenti-GFP
(n¼ 4) were harvested 3 days post wounding and processed for
histology as described above. Immunofluorescent staining followed
standard methodology. Briefly, slides were incubated with an anti-
CD45 primary antibody (1:50 dilution) overnight at 4 1C. Following
antibody incubation, slides were washed for 15minutes in phos-
phate-buffered saline. Slides were then incubated with a secondary
antibody (1:100; Alexa Fluor 488; F(ab0)2 fragment of goat anti-rabbit
antibody) for 30minutes at room temperature, followed by a
15-minute wash in PBS. Slides were mounted with 40,6-diamidino-
2-phenylindole (Vector Laboratories, Burlingame, CA) and visualized.
Three high-power fields were analyzed per slide (12 high-power
fields per Lenti-GFP- and Lenti-IL-10-injected wound).
Fluorescence stereomicroscopy
Wounds that had been injected with Lenti-IL-10 or Lenti-GFP were
harvested 1 and 3 days post wounding. The wound bed, including
the site from which the wound was harvested, as well as the area
circumferentially around the wound site, was assessed by fluorescent
stereoscopic microscopy (MZ16FA; Leica, Heerburg, Switzerland)
for GFP expression. Images were viewed using both green and red
fluorescent filters, and subsequently merged to allow detection and
elimination of background fluorescence. In this system, true GFP
fluorescence was seen only using the green filter, whereas back-
ground fluorescence was visualized using both the green and red
filters.
In vitro stromal progenitor cell transduction and IL-10
production
Stromal progenitor cells were harvested from adult C57BL/6 bone
marrow as previously described (Badillo et al., 2007). Cells were
plated in MesenCult Basal Medium (StemCell Technologies,
Vancouver, Canada) at a density of 20,000 cellswell1 in 12-well
plates, and incubated at 37 1C overnight. After 24 hours, fresh
medium with polybrene was added for 2 hours, following which
cells were incubated with either Lenti-IL-10 or Lenti-GFP at
multiplicities of infection of 0, 50, 100, 200, 400, or 800. After
48 hours, medium with the viral vector was removed and fresh
medium was added for 72 hours, following which supernatants were
collected and analyzed for the production of IL-10 protein, using a
murine-specific IL-10 ELISA as per manufacturer’s instructions (R&D
Systems, Minneapolis, MN).
RNA isolation and reverse transcription
Total cellular RNA from the wounds injected with Lenti-IL-10 or
Lenti-GFP was isolated using TRIzol reagent (Invitrogen), 3 days post
wounding, according to the manufacturer’s instructions. A 1-mg
weight of total cellular RNA was combined with 1 ml Dnase, 2ml
10Dnase buffer (Sigma, St Louis, MO), and diethylpyrocarbonate-
treated water to a total reaction volume of 20 ml for 15minutes at
room temperature. The Dnase reaction was stopped by the addition
25mM EDTA and incubation for 10minutes at 65 1C. First-strand
cDNA was prepared using SuperScript First-Strand Synthesis System
(Invitrogen) according to the manufacturer’s instructions. In brief,
8ml of the Dnase solution was added to each 0.65-ml microcen-
trifuge tube and placed on ice. A master mix was prepared and
added on ice such that the final concentration of reagents for each
sample was 2.5U ml1 SuperScript II Reverse Transcriptase,
2.5 ng ml1 of random hexamers, 1mM dithiothreitol, 500 mM
deoxytriphosphates, 50mM KCl, 20mM Tris-Cl (pH 8.4), and 5mM
MgCl2. After 10minutes at 25 1C and 50minutes at 42 1C, the reverse
transcriptase reaction was heat-inactivated by incubation for
15minutes at 70 1C.
Polymerase chain reaction
Primers specific for murine IL-6, MIP-2, MIP-1a, MCP-1, HSP47,
stromal-derived factor (SDF)-1, and glyceraldehyde-3-phosphate
dehydrogenase were chosen based on published reports, or were
selected based on published sequences deposited at NCBI GenBank
and designed using Primer Quest software (Integrated DNA
Technologies, Coralville, IA) (Table S1). PCR was performed using
the REDExtract N-Amp PCR ReadyMix (Sigma) combined with 2ml
of the reverse transcriptase reaction, and using forward and reverse
primers each at a final concentration of 0.5 mM. The samples were
kept on ice until placed in the thermocycler block (Hybaid Limited,
Manchester UK) at 94 1C for 5minutes. Samples were amplified over
30 cycles involving a 94 1C denaturation step, a 30-second 55 1C
annealing step, and a 1-minute 72 1C extension step. Upon
completing the final cycle, samples were incubated for 5minutes
at 72 1C and then stored at 4 1C.
Analysis and densitometry
A 10-ml sample of each reverse transcriptase-PCR product was
resolved by electrophoresis on a 1.5% agarose gel containing 0.5mg
ethidium bromide per milliliter. The gels were illuminated at a
wavelength of 302 nm using the UVP BioImagining Systems
(Upland, CA). Semi-quantitative analysis of individual gene expres-
sion was performed after standardization to the housekeeping gene,
glyceraldehyde-3-phosphate dehydrogenase, using densitometry
and the program ImageJ version 1.33u (http://rsb.info.nih.gov/ij).
Statistical analysis
Data are graphically represented as the mean of the respective
group±one standard error of the mean. Statistical comparisons
between groups were performed with the Student’s t-test for two
samples, assuming unequal variances. A two-tailed Pp0.05 was
considered significant.
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